Mechanisms underlying immune effects of dietary oligosaccharides

American Journal of Clinical Nutrition

Volumn 98, Issue 2, 2013, Pages

  Jeurink, Prescilla V ^a,b   Van Esch, Betty C A M ^a,b   Rijnierse, Anneke ^a,b   Garssen, Johan ^a,b   Knippels, Léon M J ^a,b  

^a DANONE RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTOGLOBULIN; CASEIN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INULIN; LINOLEIC ACID; MONOACYLGLYCEROL; OLIGOSACCHARIDE; PECTIN; PEPTIDE; POLYAMINE; PREBIOTIC AGENT; TAURINE;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM; BREAST MILK; DELAYED HYPERSENSITIVITY; DIET; FEEDING BEHAVIOR; FOOD ALLERGY; GLYCOSYLATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFANT FEEDING; INTESTINE FLORA; LACTOBACILLUS; MILK ALLERGY; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ASTHMA; CLINICAL TRIALS AS TOPIC; DERMATITIS, ATOPIC; DIET; FOOD HYPERSENSITIVITY; GASTROINTESTINAL TRACT; HUMANS; IMMUNOLOGIC FACTORS; INFANT; METAGENOME; MILK, HUMAN; MODELS, ANIMAL; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; TRISACCHARIDES;

EID: 84881245841     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.038596     Document Type: Article

References (78)

1. Roberfroid M. Prebiotics: the concept revisited. J Nutr 2007;137 (suppl):830S-7S.
2. FAO/WHO. Joint FAO/WHO expert consultation: health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available from: http://www.who.int/ foodsafety/publications/fs- management/en/probiotics.pdf (cited 29 March 2012).
3. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94.
4. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-21.
5. Clavel T, Haller D. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation. Curr Issues Intest Microbiol 2007; 8:25-43.
6. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33.
7. Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjovall H, Simren M. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil 2009;21:644-50, e27.
8. Sandek A, Anker SD, von Haehling S. The gut and intestinal bacteria in chronic heart failure. Curr Drug Metab 2009;10:22-8.
9. White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003;228:639-49.
10. Hougee S, Vriesema AJ, Wijering SC, Knippels LM, Folkerts G, Nijkamp FP, Knol J, Garssen J. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol 2010;151:107-17.
11. Scholtens PA, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LM, Knol J, Vandenplas Y. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with shortchain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr 2008;138:1141-7.
12. Schouten B, van Esch BC, Hofman GA, van Doorn SA, Knol J, Nauta AJ, Garssen J, Willemsen LE, Knippels LM. Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J Nutr 2009;139:1398-403.
13. Hofer U, Speck RF. Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol 2009;31:257-66.
14. Oozeer R, van Limpt K, Ludwig T, Ben Amor K, Martin R, Wind RD, Boehm G, Knol J. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr 2013;98(suppl):561S-71S.
15. Van't Land B, Boehm G, Garssen J. Breast milk: components with immune modulating potential and their possible role in immune mediated disease resistance. In: Watson R, Zibadi S, Preedy V, eds. Dietary components and immune function. Chapter 25. Dordrecht, Netherlands: Springer Science, 2010:25-41.
16. Nauta AJ, Ben Amor K, Knol J, Garssen J, van der Beek EM. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr 2013;98(suppl):586S-93S.
17. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002;34:291-5.
18. Georgi G, Bartke N, Wiens F, Stahl B. Functional glycans and glycoconjugates in human milk. Am J Clin Nutr 2013;98(suppl):578S-85S.
19. Albrecht S, Schols HA, van den Heuvel EG, Voragen AG, Gruppen H. Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk. Carbohydr Res 2011;346:2540-50.
20. Nommsen LA, Lovelady CA, Heinig MJ, Lonnerdal B, Dewey KG. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: the DARLING study. Am J Clin Nutr 1991;53:457-65.
21. Boehm G, Stahl B. Oligosaccharides. In: Mattila-Sandholm T, ed. Functional dairy products. Cambridge, United Kingdom: Woodhead Publishing, 2003:203-43.
22. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost 2004;92:1402-10.
23. Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA. Lewis X component in human milk binds DCSIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005;115:3256-64.
24. Eiwegger T, Stahl B, Haidl P, Schmitt J, Boehm G, Dehlink E, Urbanek R, Szepfalusi Z. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol 2010;21:1179-88.
25. Eiwegger T, Stahl B, Schmitt J, Boehm G, Gerstmayr M, Pichler J, Dehlink E, Loibichler C, Urbanek R, Szepfalusi Z. Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res 2004;56:536-40.
26. Garrido D, Kim JH, German JB, Raybould HE, Mills DA. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE 2011;6:e17315.
27. Nakhla T, Fu D, Zopf D, Brodsky NL, Hurt H. Neutral oligosaccharide content of preterm human milk. Br J Nutr 1999;82:361-7.
28. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, Jelinek J, Stahl B. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr 2010;104:1261-71.
29. Yamashita A, Hashimoto H, Fujita K, Okada M, Mori S, Kitahata S. Reverse reaction of Aspergillus niger APC-9319 alpha-galactosidase in a supersaturated substrate solution: production of alpha-linked galactooligosaccharide (alpha-GOS). Biosci Biotechnol Biochem 2005; 69:1381-8.
30. Abe C, Fujita K, Kikuchi E, Hirano S, Kuboki H, Yamashita A, Hashimoto H, Mori S, Okada M. Effects of alpha-linked galactooligosaccharide on adjuvant-induced arthritis in Wistar rats and type II collagen-induced arthritis in DBA/1J mice. Int J Tissue React 2004;26:65-73.
31. Sonoyama K, Watanabe H, Watanabe J, Yamaguchi N, Yamashita A, Hashimoto H, Kishino E, Fujita K, Okada M, Mori S, et al. Allergic airway eosinophilia is suppressed in ovalbumin-sensitized Brown Norway rats fed raffinose and alpha-linked galactooligosaccharide. J Nutr 2005;135:538-43.
32. Watanabe H, Sonoyama K, Watanabe J, Yamaguchi N, Kikuchi H, Nagura T, Aritsuka T, Fukumoto K, Kasai T. Reduction of allergic airway eosinophilia by dietary raffinose in Brown Norway rats. Br J Nutr 2004;92:247-55.
33. Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr 1999;129:1412S-7S.
34. van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G. On the presence of inulin and oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 1995;35:525-52.
35. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr 2005;41:186-90.
36. Rijnierse A, Jeurink PV, van Esch BC, Garssen J, Knippels LM. Foodderived oligosaccharides exhibit pharmaceutical properties. Eur J Pharmacol 2011;668(suppl 1):S117-23.
37. Moro GE, Stahl B, Fanaro S, Jelinek J, Boehm G, Coppa GV. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatr Suppl 2005;94:27-30.
38. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schopfer H, Bockler HM, Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005;40:36-42.
39. Veereman-Wauters G, Staelens S, Van de Broek H, Plaskie K, Wesling F, Roger LC, McCartney AL, Assam P. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J Pediatr Gastroenterol Nutr 2011;52:763-71.
40. Westerbeek EA, Hensgens RL, Mihatsch WA, Boehm G, Lafeber HN, van Elburg RM. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Acta Paediatr 2011;100:1426-31.
41. Wang J, Sampson HA. Food allergy. J Clin Invest 2011;121:827-35.
42. Branum AM, Lukacs SL. Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS data brief no. 10. Hyattsville, MD: National Center for Health Statistics, 2008:1-8.
43. Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008;121:1331-6.
44. Strobel S. Immunity induced after a feed of antigen during early life: oral tolerance v. sensitisation. Proc Nutr Soc 2001;60:437-42.
45. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004;4:379-85.
46. Hill DJ, Heine RG, Hosking CS, Brown J, Thiele L, Allen KJ, Su J, Varigos G, Carlin JB. IgE food sensitization in infants with eczema attending a dermatology department. J Pediatr 2007;151:359-63.
47. Hauk PJ. The role of food allergy in atopic dermatitis. Curr Allergy Asthma Rep 2008;8:188-94.
48. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76.
49. Grüber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP, Riedler J, Boehm G, Wahn U. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010;126:791-7.
50. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006;91: 814-9.
51. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008;138:1091-5.
52. Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E, Boehm G. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012;26(suppl):49S- 59S.
53. van Hoffen E, Ruiter B, Faber J, M'Rabet L, Knol EF, Stahl B, Arslanoglu S, Moro G, Boehm G, Garssen J. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009;64:484-7.
54. Boehm G, Jelinek J, Knol J, M'Rabet L, Stahl B, Vos P, Garssen J. Prebiotics and immune responses. J Pediatr Gastroenterol Nutr 2004;39 (suppl 3):S772-3.
55. Coppa GV, Zampini L, Galeazzi T, Gabrielli O. Prebiotics in human milk: a review. Dig Liver Dis 2006;38(suppl 2):S291-4.
56. Morrow AL, Rangel JM. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis 2004;15:221-8.
57. Gori A, Rizzardini G, Van't Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C Bandera A, Knol J, et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIVinfected adults: results of the "COPA" pilot randomized trial. Mucosal Immunol 2011;4:554-63.
58. Akbari O, Umetsu DT. Role of regulatory dendritic cells in allergy and asthma. Curr Opin Allergy Clin Immunol 2004;4:533-8.
59. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-5.
60. van Wijk F, Wehrens EJ, Nierkens S, Boon L, Kasran A, Pieters R, Knippels LM. CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin Exp Allergy 2007;37:572-81.
61. Izcue A, Powrie F. Special regulatory T-cell review: regulatory T cells and the intestinal tract-patrolling the frontier. Immunology 2008;123:6-10.
62. Kashyap M, Thornton AM, Norton SK, Barnstein B, Macey M, Brenzovich J, Shevach E, Leonard WJ, Ryan JJ. Cutting edge: CD4 T cell-mast cell interactions alter IgE receptor expression and signaling. J Immunol 2008;180:2039-43.
63. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009;9:83-9.
64. Murai M, Krause P, Cheroutre H, Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 2010;3:443-9.
65. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 2006;212:60-73.
66. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8:523-32.
67. Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol 2007;178:2961-72.
68. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
69. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-69.
70. Vos AP, Haarman M, Buco A, Govers M, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int Immunopharmacol 2006;6:1277-86.
71. Vos AP, van Esch BC, Stahl B, M'Rabet L, Folkerts G, Nijkamp FP, Garssen J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int Immunopharmacol 2007;7:1582-7.
72. Vos AP, Haarman M, van Ginkel JW, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol 2007;18:304-12.
73. van't Land B, Schijf M, van Esch BC, van Bergenhenegouwen J, Bastiaans J, Schouten B, Boon L, Garssen J. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine 2010;28:5711-7.
74. Schouten B, van Esch BC, Hofman GA, Boon L, Knippels LM, Willemsen LE, Garssen J. Oligosaccharide-induced whey-specific CD25(+) regulatory T-cells are involved in the suppression of cow milk allergy in mice. J Nutr 2010;140:835-41.
75. Schouten B, van Esch BC, Hofman GA, de Kivit S, Boon L, Knippels LM, Garssen J, Willemsen LE. A potential role for CD25+ regulatory T-cells in the protection against casein allergy by dietary non-digestible carbohydrates. Br J Nutr 2012;107:96-105.
76. Flinterman AE, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy 2006;61:370-4.
77. van Esch BC, Schouten B, de Kivit S, Hofman GA, Knippels LM, Willemsen LE, Garssen J. Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3(+) regulatory T-cells in the mesenteric lymph nodes. Pediatr Allergy Immunol 2011;22:820-6.
78. van Esch BC. Avoidance versus tolerance: new concepts for allergy management. PhD dissertation. University of Utrecht, Utrecht, Netherlands, 2011.